How many zebras are there, and where are they hiding in medical literature? A literature review of publications on rare diseases

IF 0.8 4区 医学 Q4 PHARMACOLOGY & PHARMACY
J. Walewski, Daniel L. Donovan, Mukund Nori
{"title":"How many zebras are there, and where are they hiding in medical literature? A literature review of publications on rare diseases","authors":"J. Walewski, Daniel L. Donovan, Mukund Nori","doi":"10.1080/21678707.2019.1684260","DOIUrl":null,"url":null,"abstract":"ABSTRACT Background: Reliable and accurate medical literature is essential for patients with rare diseases (affecting ~400 million people globally), their advocates, and caregivers (PACs), and health-care professionals (HCPs). Methods: We quantified the number of English-language publications on rare diseases in PubMed from 2009 to 2018. To test our search strategy, we evaluated inclusion of articles on 20 randomly selected rare diseases. We further examined 100 randomly selected articles from 2009 to 2013 and from 2014 to 2018 for journal type, article access, and PAC involvement. Results: Of the 10,882,681 articles published, 14,202 (0.13%) mentioned the MeSH term ‘rare disease’ in the title or abstract. Nineteen of 20 randomly selected diseases were included in our search results; an independent search for the ‘missing’ disease yielded no articles. Despite a numerical increase over time, there was little change in the proportion of rare disease articles. Most articles were in specialty journals, and ~2/3 were behind paywalls. The majority of rare disease manuscripts were case reports; almost no articles included PACs as authors. Conclusions: The number of high-quality medical publications on rare diseases is not commensurate with their overall prevalence and there are access barriers, highlighting an unmet need in medical literature that would benefit all stakeholders.","PeriodicalId":12118,"journal":{"name":"Expert Opinion on Orphan Drugs","volume":"7 1","pages":"513 - 519"},"PeriodicalIF":0.8000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21678707.2019.1684260","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Orphan Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21678707.2019.1684260","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 3

Abstract

ABSTRACT Background: Reliable and accurate medical literature is essential for patients with rare diseases (affecting ~400 million people globally), their advocates, and caregivers (PACs), and health-care professionals (HCPs). Methods: We quantified the number of English-language publications on rare diseases in PubMed from 2009 to 2018. To test our search strategy, we evaluated inclusion of articles on 20 randomly selected rare diseases. We further examined 100 randomly selected articles from 2009 to 2013 and from 2014 to 2018 for journal type, article access, and PAC involvement. Results: Of the 10,882,681 articles published, 14,202 (0.13%) mentioned the MeSH term ‘rare disease’ in the title or abstract. Nineteen of 20 randomly selected diseases were included in our search results; an independent search for the ‘missing’ disease yielded no articles. Despite a numerical increase over time, there was little change in the proportion of rare disease articles. Most articles were in specialty journals, and ~2/3 were behind paywalls. The majority of rare disease manuscripts were case reports; almost no articles included PACs as authors. Conclusions: The number of high-quality medical publications on rare diseases is not commensurate with their overall prevalence and there are access barriers, highlighting an unmet need in medical literature that would benefit all stakeholders.
那里有多少斑马,它们在医学文献中藏在哪里?罕见病文献综述
摘要背景:可靠和准确的医学文献对罕见病患者(影响全球约4亿人)、其倡导者和护理人员(PAC)以及医疗保健专业人员(HCP)至关重要。方法:我们量化了2009年至2018年PubMed上罕见病英文出版物的数量。为了测试我们的搜索策略,我们评估了20篇随机选择的罕见病文章的收录情况。我们进一步检查了2009年至2013年和2014年至2018年随机选择的100篇文章的期刊类型、文章访问和PAC参与情况。结果:在发表的10882681篇文章中,14202篇(0.13%)在标题或摘要中提到了MeSH术语“罕见病”。在我们的搜索结果中包括了20种随机选择的疾病中的19种;对这种“失踪”疾病的独立搜索没有发现任何文章。尽管数量随着时间的推移而增加,但罕见病文章的比例几乎没有变化。大多数文章发表在专业期刊上,约有2/3的文章发表在付费墙后面。大多数罕见病手稿是病例报告;几乎没有任何文章将PAC作为作者。结论:关于罕见病的高质量医学出版物的数量与其总体流行率不相称,而且存在获取障碍,这突出了医学文献中未满足的需求,这将使所有利益相关者受益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Expert Opinion on Orphan Drugs
Expert Opinion on Orphan Drugs PHARMACOLOGY & PHARMACY-
CiteScore
2.30
自引率
0.00%
发文量
8
期刊介绍: Expert Opinion on Orphan Drugs is an international, peer-reviewed journal that covers all aspects of R&D on rare diseases and orphan drugs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信